Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Bristol-Myers Squibb Co’s current trading price is -24.36% away from its 52-week high, while its distance from the 52-week low is 21.73%. The stock’s price range over this period has fluctuated between $39.35 and $63.33. The company, operating within the financial sector, had a trading volume of approximately 16.29 million for the day, which was noticeably higher than the average daily share volume of 13.24 million over the last 3 months.
The market performance of Bristol-Myers Squibb Co’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $63.33 on 03/11/25, while the lowest value for the same duration was $39.35 on 07/05/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Bristol-Myers Squibb Co (BMY) has experienced a quarterly decline of -19.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 97.48B and boasts a workforce of 34100 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 57.04, with a change in price of -11.37. Similarly, Bristol-Myers Squibb Co recorded 12,240,957 in trading volume during the last 100 days, posting a change of -19.18%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BMY stands at 2.95. Similarly, the long-term debt-to-equity ratio is also 2.73.
BMY Stock Stochastic Average
Today’s raw stochastic average for Bristol-Myers Squibb Co over the last 50 days is 5.91%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 6.59%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 8.53% and 9.11%, respectively.
BMY Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded a decrease of -15.31%. However, over the last six months, the performance has been stronger by -9.21%. The price of BMY decreased -19.10% over the last 30 days. And in the last five days, it has fallen by -2.70%.
